Immuneering (IMRX) Enterprise Value (2020 - 2026)
Immuneering (IMRX) posted quarterly Enterprise Value of -$156.7 million for Q1 2026, down 336.89% year-over-year from $66.1 million in Q1 2025, and up 9.34% quarter-over-quarter from -$172.8 million in Q4 2025.
Immuneering (IMRX) Enterprise Value (2020 - 2026) Analysis & Trends
Immuneering's Enterprise Value history runs 7 years deep, the most recent figure standing at -$156.7 million for Q1 2026.
- In Q1 2026, Enterprise Value fell 336.89% year-over-year to -$156.7 million; the TTM figure through Mar 2026 stood at -$156.7 million (down 336.89% YoY), while the FY2025 annual figure was -$172.8 million, down 378.16% from the prior year.
- Enterprise Value for Q1 2026 stood at -$156.7 million, up from -$172.8 million in the prior quarter.
- The five-year high for Enterprise Value was -$26.4 million in Q2 2025, with the low at -$227.6 million in Q3 2025.
- The 5-year median for Enterprise Value is -$97.2 million (2023), against an average of -$100.5 million.
- The sharpest annual moves came in 2024 and 2025: Enterprise Value surged 57.81% in 2024, then slumped 378.16% in 2025.
- Immuneering's Enterprise Value stood at -$105.5 million in 2022, then rose by 18.82% to -$85.7 million in 2023, then soared by 57.81% to -$36.1 million in 2024, then plunged by 378.16% to -$172.8 million in 2025, then increased by 9.34% to -$156.7 million in 2026.
- Business Quant data shows IMRX's Enterprise Value at -$156.7 million in Q1 2026, -$172.8 million in Q4 2025, and -$227.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -7.85 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -7.99 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | -5.18 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -3.94 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | -5.10 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -8.46 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 2.12 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -3.31 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -1.16 Bn |
| 10 | Immuneering | 327.37 Mn | 327.37 Mn | - | -149.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -149.90 Mn |
| Mar 31, 2026 | -156.69 Mn |
| Dec 31, 2025 | -172.83 Mn |
| Sep 30, 2025 | -227.56 Mn |
| Jun 30, 2025 | -26.36 Mn |
| Mar 31, 2025 | -35.87 Mn |
| Dec 31, 2024 | -36.14 Mn |
| Sep 30, 2024 | -50.66 Mn |
| Jun 30, 2024 | -59.73 Mn |
| Mar 31, 2024 | -71.28 Mn |
| Dec 31, 2023 | -85.67 Mn |
| Sep 30, 2023 | -97.24 Mn |
| Jun 30, 2023 | -108.99 Mn |
| Mar 31, 2023 | -91.54 Mn |
| Dec 31, 2022 | -105.52 Mn |
| Sep 30, 2022 | -117.20 Mn |
| Jun 30, 2022 | -128.10 Mn |
| Mar 31, 2022 | -137.77 Mn |
| Dec 31, 2021 | -149.20 Mn |
| Sep 30, 2021 | -149.48 Mn |